Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type
Phase 3
Completed
- Conditions
- Mild Cognitive ImpairmentAlzheimer DiseaseCognitive DysfunctionMild DementiaCognitive DeclineDementia, Alzheimer Type
- First Posted Date
- 2018-10-26
- Last Posted Date
- 2022-05-11
- Lead Sponsor
- Renew Research, LLC
- Target Recruit Count
- 190
- Registration Number
- NCT03721705
- Locations
- 🇺🇸
Xenoscience, Phoenix, Arizona, United States
🇺🇸Irvine Clinical Research, Irvine, California, United States
🇺🇸Charter Research, Lady Lake, Florida, United States
News
No news found